SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-017155
Filing Date
2021-05-13
Accepted
2021-05-13 12:17:32
Documents
15
Period of Report
2021-05-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nt10024340x7_8k.htm   iXBRL 8-K 37754
2 EXHIBIT 4.2 nt10024340x7_ex4-2.htm EX-4.2 638453
3 EXHIBIT 99.1 nt10024340x7_ex99-1.htm EX-99.1 20491
7 nt10024340x7_ex99-1img01.jpg GRAPHIC 62050
  Complete submission text file 0001140361-21-017155.txt   1035429

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA insm-20210513.xsd EX-101.SCH 3917
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE insm-20210513_lab.xml EX-101.LAB 22544
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insm-20210513_pre.xml EX-101.PRE 16038
8 EXTRACTED XBRL INSTANCE DOCUMENT nt10024340x7_8k_htm.xml XML 4065
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

IRS No.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30739 | Film No.: 21918170
SIC: 2834 Pharmaceutical Preparations